Incidence of hepatitis C among people who inject drugs in Ireland Anne Marie Carew, Niamh Murphy, Jean Long, Kate Hunter, Suzi Lyons, Cathal Walsh and Lelia Thornton Hepatology, Medicine and Policy 2017 2:7 https://hmap.biomedcentral.com/articl…

Das Medikament ZEPATIER kann ab 1. Juli 2017 ohne Einschränkung vergütet werden. Das Bundesamt für Gesundheit (BAG) konnte den Preis des Medikamentes um 35 Prozent senken. Das Medikament steht damit zu einem stark reduzierten Preis f&…

Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse. Lamoury FMJ, Soker A, Martinez D, Hajarizadeh B, Cunningham EB, Cunningham P, Bruggmann P, Foster GR, Dalgard O, Backmund M, Conway B, Rob…

AMSTERDAM — Contradictory findings are driving disagreement over whether patients cured of hepatitis C after treatment with direct-acting antivirals should be monitored for hepatocellular carcinoma. A flashpoint in the controversy was a…

HCV Reinfection Incidence Among Individuals Treated for Recent Infection M. Martinello; J. Grebely; K. Petoumenos; E. Gane; M. Hellard; D. Shaw; J. Sasadeusz; T. L. Applegate; G. J. Dore; G. V. Matthews J Viral Hepat. 2017;24(5):359-370. htt…

Modelling the impact of incarceration and prison-based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland. Stone, J., Martin, N. K., Hickman, M., Hutchinson, S. J., Aspinall, E., Taylor, A., Munro, A., D…